As protein concentrations rise, downstream processing faces challenges like elevated viscosity and shear stress. Mycenax leverages Merck’s Single-Pass Tangential Flow Filtration (SPTFF) solution to overcome these hurdles—successfully achieving 230 mg/mL while maintaining product quality.
As a trusted CDMO partner, Mycenax combines extensive development experience and strong collaboration with Merck to support high-concentration biologics with efficient, risk-aware solutions.
 |
As protein concentrations rise, downstream processing faces challenges like elevated viscosity and shear stress. Mycenax leverages Merck’s Single-Pass Tangential Flow Filtration (SPTFF) solution to overcome these hurdles—successfully achieving 230 mg/mL while maintaining product quality.
As a trusted CDMO partner, Mycenax combines extensive development experience and strong collaboration with Merck to support high-concentration biologics with efficient, risk-aware solutions.
|
